| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2007 | CA2635361A1 Inhibitors of checkpoint kinases |
| 07/19/2007 | CA2635360A1 Amino acid derivatives of indolinone based protein kinase inhibitors |
| 07/19/2007 | CA2635203A1 Crystalline form of 1´-(1-methylethyl)- 4´-[(2-fluoro-4-methoxyphenyl)methyl]-5´-methyl-1h-pyrazol-3´-o-.beta.-d-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
| 07/19/2007 | CA2635087A1 Cholesteryl ester transfer protein inhibitors |
| 07/19/2007 | CA2635083A1 Oxazolidinone derivatives as cetp inhibitors |
| 07/19/2007 | CA2635047A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists |
| 07/19/2007 | CA2635016A1 Treatment modalities for autoimmune diseases |
| 07/19/2007 | CA2635010A1 Oxazolidinone derivatives as cetp inhibitors |
| 07/19/2007 | CA2634566A1 Substituted oxazole derivatives with an analgesic action |
| 07/19/2007 | CA2634562A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 07/19/2007 | CA2634555A1 Diazepinones |
| 07/19/2007 | CA2634553A1 Triazole derivatives |
| 07/19/2007 | CA2633918A1 Substituted imidazoline derivatives |
| 07/19/2007 | CA2633734A1 Substituted thiazoles and their use for producing drugs |
| 07/19/2007 | CA2633731A1 Substituted thiazoles and use thereof for producing medicaments |
| 07/19/2007 | CA2633726A1 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue |
| 07/19/2007 | CA2633722A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/19/2007 | CA2633701A1 Novel, acyclically substitued furopyrimidine derivatives and use thereof |
| 07/19/2007 | CA2633698A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 07/19/2007 | CA2633633A1 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 07/19/2007 | CA2633581A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 07/19/2007 | CA2633094A1 Substituted propiolic acid amides and their use for producing analgesics |
| 07/19/2007 | CA2632962A1 Sustained release preparation and method for production thereof |
| 07/19/2007 | CA2632890A1 Method for the manufacture of a pharmaceutical form of oseltamivir phosphate |
| 07/19/2007 | CA2628186A1 Pyridopyrazine derivatives and the use thereof as medicaments in p13k related diseases |
| 07/19/2007 | CA2627695A1 Dry formulations of aripiprazole |
| 07/19/2007 | CA2627693A1 Wet granulation pharmaceutical compositions of aripiprazole |
| 07/19/2007 | CA2626641A1 Compounds |
| 07/19/2007 | CA2603249A1 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators |
| 07/19/2007 | CA2601803A1 Preventive or therapeutic agent and method for immune disease |
| 07/18/2007 | EP1808452A1 Phosphate ion adsorbent |
| 07/18/2007 | EP1808444A1 Amyloid beta protein (globular assembly and usees thereof) |
| 07/18/2007 | EP1808434A2 Use of 5-fluoro-2'-deoxy-3'-thiacytidine fo the treatment of hepatitis B |
| 07/18/2007 | EP1808432A1 Amorphous object of cinnamide compound |
| 07/18/2007 | EP1808431A1 Mutilin derivatives and their use as pharmaceutical |
| 07/18/2007 | EP1808429A2 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1808177A2 Methods of treatment of mitochondrial disorders |
| 07/18/2007 | EP1808176A2 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation |
| 07/18/2007 | EP1808175A1 Drugs, food or drink for improving pancreatic functions |
| 07/18/2007 | EP1808174A1 Medicament compositions based on tiotropium salts and on salmeterol salts |
| 07/18/2007 | EP1808173A1 Use of CNS penetrating anticancer compounds for the treatment of protozan diseases |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1808171A1 Veterinary use of pleuromultilin derivative against pneumonia in lambs, sheep and cattle |
| 07/18/2007 | EP1808170A1 Aqueous eye drops with accelerated intraocular migration |
| 07/18/2007 | EP1808169A2 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 07/18/2007 | EP1808168A1 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 07/18/2007 | EP1808167A1 Drug-eluting articles with improved drug release profiles |
| 07/18/2007 | EP1808165A1 Dry formulations of aripiprazole |
| 07/18/2007 | EP1808164A1 Wet granulation pharmaceutical compositions of aripiprazole |
| 07/18/2007 | EP1808163A1 Compressed solid dosage forms with drugs of low solubility and process for making the same |
| 07/18/2007 | EP1808162A1 Atorvastatin pharmaceutical formulation |
| 07/18/2007 | EP1808160A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/18/2007 | EP1808158A2 Presbyopia treatment by lens alteration |
| 07/18/2007 | EP1807701A2 Gpr17 modulators, method of screening and uses thereof |
| 07/18/2007 | EP1807441A2 Glucuronide metabolites and epimers thereof of tigecycline |
| 07/18/2007 | EP1807440A2 Novobiocin analogues as anticancer agents |
| 07/18/2007 | EP1807438A1 Beta-glucuronidase cleavable prodrugs of o6-alkylguanine-dna alkyltransferase inactivators |
| 07/18/2007 | EP1807435A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 07/18/2007 | EP1807434A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
| 07/18/2007 | EP1807432A1 Halogen substituted benzodiazepine derivatives |
| 07/18/2007 | EP1807431A1 Pyrrolo[1,2-d][1,2-4]triazine as inhibitors of c-jun n-terminal kinases (jnk) and p-38 kinases |
| 07/18/2007 | EP1807430A1 Hiv inhibiting bicyclic pyrimidine derivatives |
| 07/18/2007 | EP1807429A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/18/2007 | EP1807428A2 Process for preparing quinoline compounds and products obtained therefrom |
| 07/18/2007 | EP1807427A2 Substituted indolizines and derivatives as cns agents |
| 07/18/2007 | EP1807426A2 SUBSTITUTED N-ARYL-1H-PYRAZOLOÝ3,4-b¨QUINOLIN-4-AMINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS |
| 07/18/2007 | EP1807425A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 07/18/2007 | EP1807424A2 Novel kinase inhibitors |
| 07/18/2007 | EP1807423A2 Quinolinone-carboxamide compounds |
| 07/18/2007 | EP1807422A1 5-ht4 receptor agonist compounds |
| 07/18/2007 | EP1807421A1 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof |
| 07/18/2007 | EP1807420A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 07/18/2007 | EP1807419A1 (2-carboxamido)(3-amino) thiophene compounds |
| 07/18/2007 | EP1807418A2 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 07/18/2007 | EP1807415A2 Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 07/18/2007 | EP1807413A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 07/18/2007 | EP1807412A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 07/18/2007 | EP1807411A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 07/18/2007 | EP1807410A1 Compounds and compositions useful in the treatment of neoplasia |
| 07/18/2007 | EP1807409A2 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 07/18/2007 | EP1807407A1 Aromatic amides as inhibitors of c-fms kinase |
| 07/18/2007 | EP1807406A2 Inhibitors of c-fms kinase |
| 07/18/2007 | EP1807405A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 07/18/2007 | EP1807404A1 Novel use |
| 07/18/2007 | EP1807403A2 Tetracyclic indole derivatives as antiviral agents |
| 07/18/2007 | EP1807402A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 07/18/2007 | EP1807398A1 New indole or benzimidazole derivatives |
| 07/18/2007 | EP1807397A2 Tetracyclic indole derivatives as antiviral agents |
| 07/18/2007 | EP1807396A1 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/18/2007 | EP1807393A1 Diarylsulfones as 5-ht2a antagonists |
| 07/18/2007 | EP1807392A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| 07/18/2007 | EP1807391A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 07/18/2007 | EP1807390A2 Arylalkyl ureas as cb1 antagonists |
| 07/18/2007 | EP1807388A2 Acyclic hydrazides as cannabinoid receptor modulators |
| 07/18/2007 | EP1807387A2 Substituted tetracycline compounds |
| 07/18/2007 | EP1807386A1 Novel compounds useful for modulating abnormal cell proliferation |
| 07/18/2007 | EP1807383A2 Flavour modulating substances |
| 07/18/2007 | EP1807156A1 New pharmaceutical formulations useful in the treatment of insomnia |